Lipoproteins are a set of natural nanoparticles whose main role is the transport of fats within
the body. While much work has been done to develop synthetic nanocarriers to deliver …

The development of novel and effective contrast agents is one of the drivers of the ongoing
improvement in medical imaging. Many of the new agents reported are nanoparticle-based …

Radiolabeled lipidic nanoparticles, particularly liposomes and lipoproteins, are of great
interest as agents for imaging and therapy, due not only to their peculiar physicochemical …

Identifying patients at high risk for an acute cardiovascular event such as myocardial
infarction or stroke and assessing the total atherosclerotic burden are clinically important …

Lipoproteins, natural nanoparticles, have a well-recognized biological role and are highly
suitable as a platform for delivering imaging agents. The ease with which both the exterior …

Atherosclerosis is a systemic disease that affects most major arteries of the body and is the
most common cause of premature death in the western world. It develops slowly and often …

Publisher Summary This chapter discusses the clinically useful chelators of tripositive
elements. The clinical use of chelator molecules has been synonymous with the removal of …

Background Oxidatively modified low-density lipoprotein (LDL) is present in atherosclerotic
but not normal arteries and plays a crucial role in the pathogenesis and adverse …

The integration of lipoprotein-related or apolipoprotein-targeted nanoparticles as
pharmaceutical carriers opens new therapeutic and diagnostic avenues in nanomedicine …

Background. Previous experiments indicated that most antibodies binding to cell surface
antigens are internalized gradually and degraded within lysosomes, with a half‐life of …